In the News

395 News Items found
Man and woman in white lab coats looking at test tubes
In the Clinic
Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Dr. Neal Rakesh
Cancer pain is common, even after treatment has ended, so doctors at MSK have developed a number of ways to treat cancer pain and help people get back to their lives. 
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
3-D illustration (in pink) of female reproductive system anatomy
Feature
Learn how immunotherapy holds promise for transforming the treatment of gynecologic cancers.
colorful microscope image of cancer cells
MSK scientists are shedding new light on a tumor’s earliest moments — revealing how lung cells with cancer-causing mutations recruit accomplices from healthy surrounding tissue to pave the way for a tumor to develop.
physiatrist Jesuel Padro-Guzman
Q&A
Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
AACR 2019 Annual Meeting
In the News
Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Two nurses talking at a desk
Feature
Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.
A hand points to brain images on a screen.
In the Clinic
MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.